ArticleInternational journal of chronic obstructive pulmonary disease2018

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK.

Chris Kiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.